New Service: NWRL Assays are now available
New Service: NWRL Assays are now available
The leadership of the Diabetes Research Center is pleased to announce that we are now able to offer assays to affiliates through the Northwest Lipid Metabolism and Diabetes Research Laboratories (NWRL) overseen by Santica Marcovina. These assays are primarily for plasma measurements, but could be used for example on cell lysates or culture media. They will be available at reduced cost and with a rapid turnaround.
A list of analyses currently available and the cost per sample is provided on the chargeback schedule. These analytes are primarily available for measurement on samples from humans, but could also be performed on samples from other species where appropriate. Before sending samples to the NWRL, please contact Jessica Harting at the NWRL (jjc8@uw.edu), with a copy to Corinne Lovato (lovcor@uw.edu). Also, if there are analytes that are not listed that you are interested in having assayed, please contact these same two individuals and they will let you know if it is possible and will also cost it for you.
Congratulations to the 2016 DRC Award Recipients
Congratulations to the 2016 DRC Award Recipients:
Pilot & Feasibility Awards
Michael Ailion, PhD (Biochemistry)
Jenny Kanter, PhD (Medicine)
Sara Morgan, PhD, CPO (Rehab Medicine)
Click here to read more about their funded projects.
Samuel & Althea Stroum
Graduate Fellowship
Paige Wartko (Epidemiology)
Click here to read more about her funded project.
DRC Service Award
Service Award
Did you know the DRC provides small grants to cover the cost of core services?
CRISPR/Cas9 directed gene editing services now offered by the DRC!
CRISPR/Cas9 directed gene editing services now offered by the DRC!
The Viral Vector and Transgenic Mouse Core (VTMC) is pleased to now offer CRISPR/Cas9-directed gene editing services utilizing next-generation dimeric RNA-guided FokI nuclease technology. This system allows precise and efficient gene knockout and can be modified to introduce site-specific mutations into endogenous genes.
Click here to connect to the VTMC page for more information.
Welcome to the University of Washington Diabetes Research Center
The Diabetes Research Center (DRC) at the University of Washington is one of 18 Diabetes Research Centers sponsored by the National Institutes of Health to promote basic, translational, and clinical research on diabetes and related metabolic disorders.
- Since our Center’s founding over 30 years ago, our service has always focused on one priority: facilitating and enhancing diabetes research to find a cure to diabetes.
- The Diabetes Research Center serves as resource for diabetes investigators at the University of Washington and affiliated institutions.
- We continue to encourage, foster, and support all stages of diabetes-related translational research and studies.
- The ultimate goals of diabetes research are to elucidate the etiology and pathogenesis of the disease processes causing diabetes and the end-organ complications of this disease. Learn more about the DRC.
Two Large NIH Studies Currently Open for Enrollment in Seattle
The Restoring Insulin Secretion Study
The goal of the Restoring Insulin Secretion (RISE) Study is to find new approaches to prevent or treat types 2 diabetes. We're looking for adults who were recently diagnosed with diabetes or who are at risk for diabetes.
Click here to learn more about this study conducted by the Diabetes Research Group at the University of Washington.
The Glycemia Reduction Approaches in Diabetes:
A Comparative Effectiveness Study (GRADE) is a long-term study of different treatments for type 2 diabetes.
GRADE will determine which combination of two medications is best for glycemic control, has the fewest side effects, and is the most beneficial for overall health.
Click here to learn more about this study conducted by the Diabetes Research Group at the University of Washington.